{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Medicinal plant", "NMDA", "Natural product", "Oxidative stress", "Seizure", "Trigonelline"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38902338", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "20"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "23"}, "Article": {"Language": ["eng"], "ELocationID": ["14239", "10.1038/s41598-024-65301-z"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "20"}], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "20"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Trigonelline as an anticonvulsant agent: mechanistic insights into NMDA receptor expression and oxidative stress balance.", "Pagination": {"StartPage": "14239", "MedlinePgn": "14239"}, "Abstract": {"AbstractText": ["Glutamatergic neurotransmission and oxidative stress are involved in the pathophysiology of seizures. Some anticonvulsants exert their effects through modulation of these pathways. Trigonelline (TRG) has been shown to possess various pharmacological effects like neuroprotection. Therefore, this study was performed to determine TRG's anticonvulsant effects, focusing on its potential effects on N-methyl-D-aspartate (NMDA) receptors, a type of glutamate receptor, and oxidative stress state in the prefrontal cortex (PFC) in PTZ-induced seizure in mice. Seventy-two male mice were randomly divided into nine groups. The groups included mice that received normal saline, TRG at doses of 10, 50, and 100\u00a0mg/kg, diazepam, NMDA (an agonist), ketamine (an antagonist), the effective dose of TRG with NMDA, as well as sub-effective dose of TRG with ketamine, respectively. All agents were administrated intraperitoneally 60\u00a0min before induction of seizures by PTZ. Latency to seizure, total antioxidant capacity (TAC), and malondialdehyde (MDA) levels in serum and PFC were measured. Furthermore, the gene expression of NR2A and NR2B, subunits of NMDA receptors, was measured in the PFC. TRG administration increased the latency to seizure onset and enhanced TAC while reducing MDA levels in both the PFC and serum. TRG also decreased the gene expression of NR2B in the PFC. Unexpectedly, the findings revealed that the concurrent administration of ketamine amplified, whereas NMDA mitigated, the impact of TRG on latency to seizure. Furthermore, NMDA diminished the positive effects of TRG on antioxidant capacity and oxidative stress, while ketamine amplified these beneficial effects, indicating a complex interaction between TRG and NMDA receptor modulation. In the gene expression of NMDA receptors, results showed that ketamine significantly decreased the gene expression of NR2B when co-administrated with a sub-effective dose of TRG. It was found that, at least partially, the anticonvulsant effect of TRG in PTZ-induced seizures in male mice was mediated by the attenuation of glutamatergic neurotransmission as well as the reduction of oxidative stress."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran."}], "LastName": "Kabiri-Samani", "ForeName": "Nastran", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran."}], "LastName": "Amini-Khoei", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran."}], "LastName": "Rahimi-Madiseh", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands-IUNICS, 07122, Palma de Mallorca, Spain."}, {"Identifier": [], "Affiliation": "CIBEROBN (Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, 28029, Madrid, Spain."}, {"Identifier": [], "Affiliation": "Health Research Institute of Balearic Islands (IdISBa), 07120, Palma, Balearic Islands, Spain."}], "LastName": "Sureda", "ForeName": "Antoni", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Z.lorigooini@gmail.com."}], "LastName": "Lorigooini", "ForeName": "Zahra", "Initials": "Z"}], "GrantList": [{"GrantID": "3951", "Agency": "Shahrekord University of Medical Sciences", "Country": ""}, {"GrantID": "3951", "Agency": "Shahrekord University of Medical Sciences", "Country": ""}, {"GrantID": "3951", "Agency": "Shahrekord University of Medical Sciences", "Country": ""}, {"GrantID": "3951", "Agency": "Shahrekord University of Medical Sciences", "Country": ""}, {"GrantID": "CIBEROBN CB12/03/30038", "Agency": "Instituto de Salud Carlos III", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Receptors, N-Methyl-D-Aspartate"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "3NQ9N60I00", "NameOfSubstance": "trigonelline"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "NR2B NMDA receptor"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "690G0D6V8H", "NameOfSubstance": "Ketamine"}, {"RegistryNumber": "WM5Z385K7T", "NameOfSubstance": "Pentylenetetrazole"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, N-Methyl-D-Aspartate"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["drug therapy", "metabolism", "chemically induced"], "DescriptorName": "Seizures"}, {"QualifierName": ["metabolism", "drug effects"], "DescriptorName": "Prefrontal Cortex"}, {"QualifierName": ["metabolism"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ketamine"}, {"QualifierName": ["toxicity"], "DescriptorName": "Pentylenetetrazole"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Thurman DJ, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011;52:2\u201326. doi: 10.1111/j.1528-1167.2011.03121.x.", "ArticleIdList": ["10.1111/j.1528-1167.2011.03121.x", "21899536"]}, {"Citation": "Strauss DJ, Day SM, Shavelle RM, Wu YW. Remote symptomatic epilepsy: Does seizure severity increase mortality? Neurology. 2003;60:395\u2013399. doi: 10.1212/WNL.60.3.395.", "ArticleIdList": ["10.1212/WNL.60.3.395", "12578917"]}, {"Citation": "Zhang YJ, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of idiopathic epilepsy epidemiology from 1990 to 2019. Prev. Med. Rep. 2023;36:102522. doi: 10.1016/j.pmedr.2023.102522.", "ArticleIdList": ["10.1016/j.pmedr.2023.102522", "PMC10728447", "38116287"]}, {"Citation": "Nasiri J, Ghazzavi M, Sedghi M, Pirzadeh Z. Causes and risk factors of drug-resistant epilepsy in children. Iran J. Child Neurol. 2023;17:89\u201397. doi: 10.22037/ijcn.v17i1.33814.", "ArticleIdList": ["10.22037/ijcn.v17i1.33814", "PMC10448845", "37637781"]}, {"Citation": "Bourgeois BF, Dodson E, Nordli DR, Pellock JM, Sankar R. Pediatric Epilepsy: Diagnosis and Therapy. Demos Medical Publishing; 2007."}, {"Citation": "Ho Y-H, et al. Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus. J. Biomed. Sci. 2015;22:1\u201314. doi: 10.1186/s12929-015-0157-8.", "ArticleIdList": ["10.1186/s12929-015-0157-8", "PMC4477313", "26100815"]}, {"Citation": "Chapman AG. Glutamate and epilepsy. J. Nutr. 2000;130:1043S\u20131045S. doi: 10.1093/jn/130.4.1043S.", "ArticleIdList": ["10.1093/jn/130.4.1043S", "10736378"]}, {"Citation": "Chen HSV, Lipton SA. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 2006;97:1611\u20131626. doi: 10.1111/j.1471-4159.2006.03991.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.03991.x", "16805772"]}, {"Citation": "Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat. Neurosci. 2002;5:1039\u20131042. doi: 10.1038/nn936.", "ArticleIdList": ["10.1038/nn936", "12403981"]}, {"Citation": "Liu W, et al. The effects of herbal medicine on epilepsy. Oncotarget. 2017;8:48385\u201348397. doi: 10.18632/oncotarget.16801.", "ArticleIdList": ["10.18632/oncotarget.16801", "PMC5564656", "28423368"]}, {"Citation": "Rehman MU, et al. Neuroprotective strategies for neurological disorders by natural products: An update. Curr. Neuropharmacol. 2019;17:247\u2013267. doi: 10.2174/1570159x16666180911124605.", "ArticleIdList": ["10.2174/1570159x16666180911124605", "PMC6425075", "30207234"]}, {"Citation": "Lorigooini Z, Dehsahraei KS, Bijad E, Dehkordi SH, Amini-Khoei H. Trigonelline through the attenuation of oxidative stress exerts antidepressant-and anxiolytic-like effects in a mouse model of maternal separation stress. Pharmacology. 2020;105:289\u2013299. doi: 10.1159/000503728.", "ArticleIdList": ["10.1159/000503728", "31630147"]}, {"Citation": "Faizan M, et al. Neuroprotective effects of trigonelline in kainic acid-induced epilepsy: Behavioral, biochemical, and functional insights. Saudi Pharm. J. 2023;31:101843. doi: 10.1016/j.jsps.2023.101843.", "ArticleIdList": ["10.1016/j.jsps.2023.101843", "PMC10638067", "37961069"]}, {"Citation": "Wong S, et al. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem. 1987;33:214\u2013220. doi: 10.1093/clinchem/33.2.214.", "ArticleIdList": ["10.1093/clinchem/33.2.214", "3802504"]}, {"Citation": "Mirzaie M, Khalili M, Kiasalari Z, Roghani M. Neuroprotective and antiapoptotic potential of trigonelline in a striatal 6-hydroxydopamine rat model of Parkinson\u2019s disease. Neurophysiology. 2016;48:176\u2013183. doi: 10.1007/s11062-016-9586-6.", "ArticleIdList": ["10.1007/s11062-016-9586-6"]}, {"Citation": "Kim DH, et al. Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology. 2010;59:20\u201330. doi: 10.1016/j.neuropharm.2010.03.012.", "ArticleIdList": ["10.1016/j.neuropharm.2010.03.012", "20363233"]}, {"Citation": "Kuloglu M, Atmaca M, Tezcan E, Ustundag B, Bulut S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology. 2002;46:186\u2013189. doi: 10.1159/000067810.", "ArticleIdList": ["10.1159/000067810", "12566935"]}, {"Citation": "Lorigooini Z, Salimi N, Soltani A, Amini-Khoei H. Implication of NMDA-NO pathway in the antidepressant-like effect of ellagic acid in male mice. Neuropeptides. 2019;76:101928. doi: 10.1016/j.npep.2019.04.003.", "ArticleIdList": ["10.1016/j.npep.2019.04.003", "31078318"]}, {"Citation": "Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001;50:537\u2013546.", "ArticleIdList": ["11829314"]}, {"Citation": "Cendes F, et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology. 1993;43:719\u2013719. doi: 10.1212/WNL.43.4.719.", "ArticleIdList": ["10.1212/WNL.43.4.719", "8469329"]}, {"Citation": "Benzie IF, Strain J. [2] Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15\u201327. doi: 10.1016/S0076-6879(99)99005-5.", "ArticleIdList": ["10.1016/S0076-6879(99)99005-5", "9916193"]}, {"Citation": "Nasiri-Boroujeni S, et al. NMDA receptor mediates the anticonvulsant effect of hydroalcoholic extract of artemisia persica in PTZ-induced seizure in mice. Evid.-Based Complement. Alternative Med. 2021;2021:1\u20138. doi: 10.1155/2021/6422451.", "ArticleIdList": ["10.1155/2021/6422451", "PMC8360731", "34394390"]}, {"Citation": "Ashihara H, et al. Trigonelline and related nicotinic acid metabolites: Occurrence, biosynthesis, taxonomic considerations, and their roles in planta and in human health. Phytochem. Rev. 2015;14:765\u2013798. doi: 10.1007/s11101-014-9375-z.", "ArticleIdList": ["10.1007/s11101-014-9375-z"]}, {"Citation": "Ilavenil S, et al. Trigonelline attenuates the adipocyte differentiation and lipid accumulation in 3T3-L1 cells. Phytomedicine. 2014;21:758\u2013765. doi: 10.1016/j.phymed.2013.11.007.", "ArticleIdList": ["10.1016/j.phymed.2013.11.007", "24369814"]}, {"Citation": "Zhou J, Chan L, Zhou S. Trigonelline: A plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr. Med. Chem. 2012;19:3523\u20133531. doi: 10.2174/092986712801323171.", "ArticleIdList": ["10.2174/092986712801323171", "22680628"]}, {"Citation": "Assad T, Khan RA. Effect of methanol extract of Trigonella foenum-graecum L. seeds on anxiety, sedation and motor coordination. Metabol. Brain Dis. 2017;32:343\u2013349. doi: 10.1007/s11011-016-9914-y.", "ArticleIdList": ["10.1007/s11011-016-9914-y", "27639708"]}, {"Citation": "Omidi-Ardali H, Lorigooini Z, Soltani A, Balali-Dehkordi S, Amini-Khoei H. Inflammatory responses bridge comorbid cardiac disorder in experimental model of IBD induced by DSS: Protective effect of the trigonelline. Inflammopharmacology. 2019;27:1265\u20131273. doi: 10.1007/s10787-019-00581-w.", "ArticleIdList": ["10.1007/s10787-019-00581-w", "30924005"]}, {"Citation": "Gaur V, Bodhankar SL, Mohan V, Thakurdesai PA. Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson\u2019s disease. Pharmaceut. Biol. 2013;51:550\u2013557. doi: 10.3109/13880209.2012.747547.", "ArticleIdList": ["10.3109/13880209.2012.747547", "23368940"]}, {"Citation": "Steinlein OK, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor \u03b14 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 1995;11:201\u2013203. doi: 10.1038/ng1095-201.", "ArticleIdList": ["10.1038/ng1095-201", "7550350"]}, {"Citation": "Franke H, Kittner H. Morphological alterations of neurons and astrocytes and changes in emotional behavior in pentylenetetrazol-kindled rats. Pharmacol. Biochem. Behav. 2001;70:291\u2013303. doi: 10.1016/S0091-3057(01)00612-8.", "ArticleIdList": ["10.1016/S0091-3057(01)00612-8", "11701200"]}, {"Citation": "Pravalika K, et al. Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke. Life Sci. 2019;216:49\u201358. doi: 10.1016/j.lfs.2018.11.014.", "ArticleIdList": ["10.1016/j.lfs.2018.11.014", "30414429"]}, {"Citation": "Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005;14:34\u201345. doi: 10.1159/000085384.", "ArticleIdList": ["10.1159/000085384", "15956813"]}, {"Citation": "Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta. 2001;303:19\u201324. doi: 10.1016/S0009-8981(00)00337-5.", "ArticleIdList": ["10.1016/S0009-8981(00)00337-5", "11163018"]}, {"Citation": "Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta BBA Bioenerget. 1998;1366:211\u2013223. doi: 10.1016/S0005-2728(98)00114-5.", "ArticleIdList": ["10.1016/S0005-2728(98)00114-5", "9714810"]}, {"Citation": "Zhou J-Y, Zhou S-W. Protection of trigonelline on experimental diabetic peripheral neuropathy. Evid.-Based Complement. Alternat. Med. 2012;2012:1\u20138.", "ArticleIdList": ["PMC3526196", "23304193"]}, {"Citation": "Yoshinari O, Takenake A, Igarashi K. Trigonelline ameliorates oxidative stress in type 2 diabetic Goto-Kakizaki rats. J. Med. Food. 2013;16:34\u201341. doi: 10.1089/jmf.2012.2311.", "ArticleIdList": ["10.1089/jmf.2012.2311", "23256445"]}, {"Citation": "Mohamadi N, Sharififar F, Pournamdari M, Ansari M. A review on biosynthesis, analytical techniques, and pharmacological activities of trigonelline as a plant alkaloid. J. Dietary Suppl. 2018;15:207\u2013222. doi: 10.1080/19390211.2017.1329244.", "ArticleIdList": ["10.1080/19390211.2017.1329244", "28816550"]}, {"Citation": "Zhu X, et al. NMDA receptor NR2B subunits contribute to PTZ-kindling-induced hippocampal astrocytosis and oxidative stress. Brain Res. Bull. 2015;114:70\u201378. doi: 10.1016/j.brainresbull.2015.04.002.", "ArticleIdList": ["10.1016/j.brainresbull.2015.04.002", "25896886"]}, {"Citation": "Mikuni N, et al. NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia. 1999;40:1683\u20131687. doi: 10.1111/j.1528-1157.1999.tb01584.x.", "ArticleIdList": ["10.1111/j.1528-1157.1999.tb01584.x", "10612330"]}, {"Citation": "Mathern GW, et al. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain J. Neurol. 1997;120:1937\u20131959. doi: 10.1093/brain/120.11.1937.", "ArticleIdList": ["10.1093/brain/120.11.1937", "9397013"]}, {"Citation": "Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol. Rev. 1999;51:7\u201362.", "ArticleIdList": ["10049997"]}, {"Citation": "Mayer ML. Glutamate receptor ion channels. Curr. Opin. Neurobiol. 2005;15:282\u2013288. doi: 10.1016/j.conb.2005.05.004.", "ArticleIdList": ["10.1016/j.conb.2005.05.004", "15919192"]}, {"Citation": "Traynelis SF, et al. Glutamate receptor ion channels: Structure, regulation, and function. Pharmacol. Rev. 2010;62:405\u2013496. doi: 10.1124/pr.109.002451.", "ArticleIdList": ["10.1124/pr.109.002451", "PMC2964903", "20716669"]}, {"Citation": "Paoletti P, Neyton J. NMDA receptor subunits: Function and pharmacology. Curr. Opin. Pharmacol. 2007;7:39\u201347. doi: 10.1016/j.coph.2006.08.011.", "ArticleIdList": ["10.1016/j.coph.2006.08.011", "17088105"]}, {"Citation": "Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82:279\u2013293. doi: 10.1016/j.neuron.2014.03.030.", "ArticleIdList": ["10.1016/j.neuron.2014.03.030", "24742457"]}, {"Citation": "Bayer TA, Wiestler OD, Wolf HK. Hippocampal loss of N-methyl-D-aspartate receptor subunit 1 mRNA in chronic temporal lobe epilepsy. Acta Neuropathol. 1995;89:446\u2013450. doi: 10.1007/BF00307650.", "ArticleIdList": ["10.1007/BF00307650", "7618442"]}, {"Citation": "Zia SR, Wasim M, Ahmad S. Unlocking therapeutic potential of trigonelline through molecular docking as a promising approach for treating diverse neurological disorders. Metabol. Brain Dis. 2023;38:2721\u20132733. doi: 10.1007/s11011-023-01304-5.", "ArticleIdList": ["10.1007/s11011-023-01304-5", "37851136"]}, {"Citation": "Farid MM, Yang X, Kuboyama T, Tohda C. Trigonelline recovers memory function in Alzheimer\u2019s disease model mice: Evidence of brain penetration and target molecule. Sci. Rep. 2020;10:1\u201310. doi: 10.1038/s41598-020-73514-1.", "ArticleIdList": ["10.1038/s41598-020-73514-1", "PMC7532147", "33009465"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "4"}, {"Year": "2024", "Month": "6", "Day": "19"}, {"Year": "2024", "Month": "6", "Day": "21", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "21", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "20", "Hour": "23", "Minute": "20"}, {"Year": "2024", "Month": "6", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["38902338", "PMC11189925", "10.1038/s41598-024-65301-z", "10.1038/s41598-024-65301-z"]}}]}